Current Advances in the Pathophysiology and Treatment of Multiple Sclerosis and Related Disorders
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 10 September 2025 | Viewed by 45
Special Issue Editors
Interests: clinical neuroscience; Tourette syndrome; obsessive compulsive disorder; Tourette associations networking
Special Issues, Collections and Topics in MDPI journals
Interests: multiple sclerosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) that can severely impair a patient’s physical, social, and mental abilities. Diagnosis is not always straightforward, especially in case of the primary progressive type, and often, MS should be differentiated from other demyelinating disorders of the CNS such as neuromyelitis optica spectrum disorder (NMO-SD), MOGAD, and vasculitis affecting the CNS.
In this Special Issue, we present current advances in the pathophysiology and treatment of MS and related disorder, with special attention to new technologies used in the diagnosis of these disorders, novel biomarkers and pathophysiological pathways, and innovative treatment targets, for example, focusing on remyelination or resetting of the immunological system.
Dr. Natalia Szejko
Dr. Sara Samadzadeh
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple sclerosis
- MS
- central nervous system
- pathophysiology
- immunological system
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
